Start-up developing ”digital twin” received award during the EIT Health Summit

A biotech company, a medtech company and a company in digital health were on the podium when the EIT Health Catapult awarded its winners.

The EIT Health Summit took place at the Karolinska Institutet in Solna earlier this week, as the European congress was held in Sweden for the first time.

On Tuesday, nine finalists in the start-up competition EIT Health Catapult pitched their ideas in three categories during a congress session at Karolinska Institutets Aula Medica. The finalists competed in the categories biotech, medtech and digital health. The companies that made it to the finals were briefly introduced by one person from each company.

The German company Ebenbuild develops AI and aims to produce a “digital twin” for a patient's lungs. The technology aims to improve care for patients with acute respiratory distress syndrome. Ebenbuild won the digital health category.

The biotech category was won by the British company SolasCure, which develops treatments for chronic wounds.

The winner in the Medtech category was the Spanish company Leuko, which develops a non-invasive technology for monitoring white blood cells.

The participants in the congress also voted for a winner among the finalists for the Alex Casta Audience Award, leaving the Irish company Luminate Medical with the most votes. The company develops technology to prevent hair loss in connection with chemotherapy for cancer treatment. As the prize, the company will have its logo displayed on the Nasdaq Tower in Times Square, New York.

EIT Health Catapult aims to contribute to the development of start-ups in the field of health and to present these companies to experts and investors.

Artikeln är en del av vårt tema om News in English.

Kommentera en artikel
Utvalda artiklar


Sänd till en kollega